Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
Callender, Tom, Emberton, Mark, Morris, Steve, Eeles, Ros, Kote-Jarai, Zsofia, Pharoah, Paul D. P., Pashayan, Nora, Shapiro, Steven D.Volume:
16
Journal:
PLOS Medicine
DOI:
10.1371/journal.pmed.1002998
Date:
December, 2019
Fichier:
PDF, 777 KB
2019
File converter
Plus de résultats de recherche
More benefits 
